Frontiers in Psychiatry (Apr 2020)
Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
Abstract
No abstracts available.Keywords
Frontiers in Psychiatry (Apr 2020)